<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss1full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.palgrave-journals.com/~d/styles/itemcontent.css"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
<channel rdf:about="http://www.palgrave-journals.com/jgm/current_issue/rss">
<title>Journal of Generic Medicines - Issue</title>
<description>Journal of Generic Medicines publishes analyses, briefings and updates which are of direct relevance to practitioners and that meet the highest intellectual standards.</description>
<link>http://www.palgrave-journals.com/jgm/current_issue/</link>
<admin:generatorAgent rdf:resource="http://www.nature.com/" />
<admin:errorReportsTo rdf:resource="mailto:feedback@nature.com" />
<dc:publisher>Palgrave Macmillan Ltd</dc:publisher>
<dc:language>en</dc:language>
<dc:rights />
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<prism:issn>1741-1343</prism:issn>
<prism:copyright />
<prism:rightsAgent>rights@palgrave.com</prism:rightsAgent>
<image rdf:resource="http://www.palgrave-journals.com/pal/images/logos_b_o_w/jgm.gif" />
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.31" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.20" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.26" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.21" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.23" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.27" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.25" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.29" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.24" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.30" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.28" />
<rdf:li rdf:resource="http://dx.doi.org/10.1057/jgm.2009.22" />
</rdf:Seq>
</items>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.palgrave-journals.com/jgm/rss/current" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /></channel>
<image rdf:about="http://www.palgrave-journals.com/pal/images/logos_b_o_w/jgm.gif">
<title>Journal of Generic Medicines</title>
<url>http://www.palgrave-journals.com/pal/images/logos_b_o_w/jgm.gif</url>
<link>http://www.palgrave-journals.com/jgm/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.31">
<title>The pharmaceutical market of the future: Will there be unfair delays for the entry of generics in the biotechnology era?</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/sGL0j5pC1UY/jgm.2009.31</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/sGL0j5pC1UY" height="1" width="1"/>]]></content:encoded>
<dc:title>The pharmaceutical market of the future: Will there be unfair delays for the entry of generics in the biotechnology era?</dc:title>
<dc:creator>Maria Fabiana Jorge</dc:creator>
<dc:creator />
<dc:identifier>doi:10.1057/jgm.2009.31</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 293 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.31</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.20">
<title>Developing a legislative pathway for biosimilars in the United States</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/JPLaNwjoNZU/jgm.2009.20</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/JPLaNwjoNZU" height="1" width="1"/>]]></content:encoded>
<dc:title>Developing a legislative pathway for biosimilars in the United States</dc:title>
<dc:creator>Henry A Waxman</dc:creator>
<dc:creator />
<dc:identifier>doi:10.1057/jgm.2009.20</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 295 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.20</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.26">
<title>Opportunities and challenges in an ever generic world</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/EUTy6gVGqdQ/jgm.2009.26</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/EUTy6gVGqdQ" height="1" width="1"/>]]></content:encoded>
<dc:title>Opportunities and challenges in an ever generic world</dc:title>
<dc:creator>Alan Sheppard</dc:creator>
<dc:creator />
<dc:identifier>doi:10.1057/jgm.2009.26</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 303 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.26</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.21">
<title>Mergers &amp; Acquisitions update: Changing the strategic paradigm in the global generics market</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/vgiiSrfrP6o/jgm.2009.21</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/vgiiSrfrP6o" height="1" width="1"/>]]></content:encoded>
<dc:title>Mergers &amp; Acquisitions update: Changing the strategic paradigm in the global generics market</dc:title>
<dc:creator>Vijay P Karwal</dc:creator>
<dc:creator />
<dc:identifier>doi:10.1057/jgm.2009.21</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 315 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.21</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.23">
<title>A review of recent developments at the multilateral level with respect to intellectual property and the pharmaceutical industry</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/YtlqTlUabJU/jgm.2009.23</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/YtlqTlUabJU" height="1" width="1"/>]]></content:encoded>
<dc:title>A review of recent developments at the multilateral level with respect to intellectual property and the pharmaceutical industry</dc:title>
<dc:creator>Maximiliano Santa Cruz</dc:creator>
<dc:creator>Pedro Roffe</dc:creator>
<dc:creator />
<dc:identifier>doi:10.1057/jgm.2009.23</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 323 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.23</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.27">
<title>Presence of Indian pharmaceutical industries in US market: An empirical analysis</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/WZL45Ufxvhk/jgm.2009.27</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/WZL45Ufxvhk" height="1" width="1"/>]]></content:encoded>
<dc:title>Presence of Indian pharmaceutical industries in US market: An empirical analysis</dc:title>
<dc:creator>Deepak Kumar Jena</dc:creator>
<dc:creator>Vishwajeet Mohan</dc:creator>
<dc:creator>Padmanabhuni Venkata Appaji</dc:creator>
<dc:creator>Lanka Srinivas</dc:creator>
<dc:creator>Poduri Balaram</dc:creator>
<dc:creator />
<dc:identifier>doi:10.1057/jgm.2009.27</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 333 (August 2009)</dc:source>
<dc:date>August 4, 2009</dc:date>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<prism:publicationDate>August 4, 2009</prism:publicationDate>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.27</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.25">
<title>The Brazilian generic market</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/1e6e55V_sHg/jgm.2009.25</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/1e6e55V_sHg" height="1" width="1"/>]]></content:encoded>
<dc:title>The Brazilian generic market</dc:title>
<dc:creator>Luciano M Piochi Lobo</dc:creator>
<dc:creator />
<dc:identifier>doi:10.1057/jgm.2009.25</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 345 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.25</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.29">
<title>Tendering short-term pricing policies and the impact on patients, governments and the sustainability of the generic medicines industry</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/FqsNbeB1vBw/jgm.2009.29</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/FqsNbeB1vBw" height="1" width="1"/>]]></content:encoded>
<dc:title>Tendering short-term pricing policies and the impact on patients, governments and the sustainability of the generic medicines industry</dc:title>
<dc:creator>Hugo Carradinha</dc:creator>
<dc:creator />
<dc:identifier>doi:10.1057/jgm.2009.29</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 351 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.29</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.24">
<title>Assessment of generic drug discount programs offered by large chain pharmacies in the United States</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/ONE8l5XpJIc/jgm.2009.24</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/ONE8l5XpJIc" height="1" width="1"/>]]></content:encoded>
<dc:title>Assessment of generic drug discount programs offered by large chain pharmacies in the United States</dc:title>
<dc:creator>Nilanjana Dwibedi</dc:creator>
<dc:creator>Sujit S Sansgiry</dc:creator>
<dc:creator />
<dc:identifier>doi:10.1057/jgm.2009.24</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 363 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.24</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.30">
<title>Abbott v. Sandoz: Judicial clarity on the interpretation of product-by-process claims</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/a6ffi-i_ls4/jgm.2009.30</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/a6ffi-i_ls4" height="1" width="1"/>]]></content:encoded>
<dc:title>Abbott v. Sandoz: Judicial clarity on the interpretation of product-by-process claims</dc:title>
<dc:creator>Frederick H Rein</dc:creator>
<dc:creator>Joseph B Crystal</dc:creator>
<dc:identifier>doi:10.1057/jgm.2009.30</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 369 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.30</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.28">
<title>Local patent rules becoming more of a factor in popular patent jurisdictions</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/My83BehFQ-s/jgm.2009.28</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/My83BehFQ-s" height="1" width="1"/>]]></content:encoded>
<dc:title>Local patent rules becoming more of a factor in popular patent jurisdictions</dc:title>
<dc:creator>Jill M Browning</dc:creator>
<dc:identifier>doi:10.1057/jgm.2009.28</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 379 (August 2009)</dc:source>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.28</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1057/jgm.2009.22">
<title>Pharmaceutical; trademark; news</title>
<link>http://feeds.palgrave-journals.com/~r/jgm/rss/current/~3/k_XjqubOvtA/jgm.2009.22</link>
<content:encoded><![CDATA[

<img src="http://feeds.feedburner.com/~r/jgm/rss/current/~4/k_XjqubOvtA" height="1" width="1"/>]]></content:encoded>
<dc:title>Pharmaceutical; trademark; news</dc:title>
<dc:creator>Richard Milchior</dc:creator>
<dc:creator>Séverine Charbonnel</dc:creator>
<dc:identifier>doi:10.1057/jgm.2009.22</dc:identifier>
<dc:source>Journal of Generic Medicines 6, 387 (August 2009)</dc:source>
<dc:date>July 21, 2009</dc:date>
<prism:publicationName>Journal of Generic Medicines</prism:publicationName>
<prism:publicationDate>July 21, 2009</prism:publicationDate>
<feedburner:origLink>http://dx.doi.org/10.1057/jgm.2009.22</feedburner:origLink></item>
</rdf:RDF>
